Vanguard Capital Management reports 5% Repligen (RGEN) stake in Schedule 13G
Rhea-AI Filing Summary
Vanguard Capital Management reports beneficial ownership of 2,825,579 shares of Repligen Corp common stock, representing 5% of the class. Vanguard has sole voting power over 414,408 shares and sole dispositive power over all 2,825,579 shares, with no shared voting or dispositive power.
The filing explains that these securities are held across Vanguard Capital Management LLC and several affiliated entities and business divisions, including various Vanguard funds and managed accounts. Vanguard and its registered investment companies and other accounts have the right to receive dividends and sale proceeds, but no other single person has an interest in more than 5% of the securities reported.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
beneficially owned financial
sole dispositive power financial
sole voting power financial
Schedule 13G regulatory
percent of class financial
AI-generated analysis. How Rhea-AI works. Not financial advice.